top of page
Search

Plexuspharmaco GmbH Granted NAFDAC Approval, Set to Bring EU-Quality Food Supplements to Nigeria

Date: April 10, 2024

In a significant milestone for both the company and consumers in Nigeria, Plexuspharmaco GmbH has secured approval from the National Agency for Food and Drug Administration and Control (NAFDAC) for its food supplements manufacturing unit. This approval marks a pivotal moment for Plexuspharmaco as it prepares to introduce EU-quality products to the Nigerian market, promising enhanced health and wellness for consumers across the nation.

Plexuspharmaco GmbH, renowned for its commitment to excellence and adherence to stringent quality standards, is poised to revolutionize the neutraceutical industry in Nigeria. With the NAFDAC seal of approval, Plexuspharmaco's state-of-the-art manufacturing facility is now authorized to produce a diverse range of products, including tablets, capsules, soft gels, powder formulations, and liquid formulations in the neutraceutical category.

The approval underscores Plexuspharmaco's unwavering dedication to delivering premium-quality supplements that meet international standards. By leveraging cutting-edge manufacturing techniques and adhering to EU regulations, Plexuspharmaco ensures that its products not only meet but exceed the expectations of consumers, offering a reliable source of health and wellness support.

Dr. Avinash J. Aher, Managing Director of Plexuspharmaco GmbH, expressed his enthusiasm regarding the approval, stating, "We are thrilled to receive NAFDAC's endorsement for our food supplements manufacturing unit. This milestone not only validates our commitment to quality but also paves the way for us to bring world-class products to the Nigerian market."

With a diverse portfolio of products spanning various formulations, Plexuspharmaco is poised to cater to the unique health needs of Nigerian consumers. From addressing nutritional deficiencies to promoting overall well-being, Plexuspharmaco's offerings are designed to empower individuals to lead healthier, more fulfilling lives.

The approval from NAFDAC comes at a time of growing demand for high-quality supplements in Nigeria, reflecting an increasing awareness of the importance of preventive healthcare. By introducing EU-quality products, Plexuspharmaco aims to raise the standard of the neutraceutical industry in Nigeria, fostering trust and confidence among consumers.

As Plexuspharmaco prepares to launch its products into the Nigerian market, consumers can look forward to accessing a comprehensive range of supplements backed by scientific research and manufactured to the highest standards of quality and safety. With Plexuspharmaco's commitment to excellence, Nigeria is poised to embark on a journey towards enhanced health and wellness for all.

For more information about Plexuspharmaco GmbH and its range of products, visit www.plexuspharmaco.eu.

Contact us at: info@plexuspharmaco.eu / avinash.aher@plexuspharmaco.eu; Mob: +49 176 2808 6910

19 views0 comments

Comments


bottom of page